Solaray Vitex Berry 400mg 100 Capsules
Vitex, also known as Chaste Tree or Chaseberry is a plant which has long been used as a medicinal herb. Vitex Berry is commonly used to relieve symptoms of PMS and Menopause, has been used to clear up acne, and may help to improve female fertility. Solaray Vitex Berry contains 400mg of Vitex per serving and comes in a vegan and vegetarian friendly formula.
Solaray Vitex 400mg 100 Capsules Highlights & Benefits
- May Help Relieve Symptoms of PMS & Menopause
- May Help Improve Female Fertility
- May Help Clear Acne
- Vegan & Vegetarian Friendly
Directions
Take 1 capsule twice daily with a meal or a glass of water.
Solaray Vitex Berry 400mg 100 Capsules Ingredients
Serving Size 1 VegCap
Amount Per Serving % Daily Value
Vitex (Vitex agnus-castus) (berry) 400 mg *
*Daily Value not established.
Other Ingredients: Vegetable Cellulose Capsule.
Warnings & Side Effects
Store in a cool dry place after opening.
References
van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562-75. doi: 10.1055/s-0032-1327831. Epub 2012 Nov 7. PMID: 23136064.
https://pubmed.ncbi.nlm.nih.gov/23136064/
†We make every effort to ensure that the product images displayed on our website faithfully represent what you will receive. However, we recognize that digital representations can sometimes fall short of capturing every nuance of the product's physical attributes. Differences in color, size, and packaging details might exist. To mitigate this, we advise our valued customers to delve into the product descriptions where the specific features, ingredients, and usage instructions of each product are meticulously outlined. This approach helps bridge the gap between expectation and reality, ensuring you are fully informed about your purchase.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, cure, diagnose, or prevent any disease.
